Work

Presentations by Peter Sampson on M4ND and M4K Pharma

Year: 2025

Type: article

Abstract: Presentations by Peter Sampson (VP Drug Discovery and Development, Agora Open Science Trust) on M4ND and M4K Pharma. Given at the 2025 Conscience Symposium on Open Drug Discovery. Small Molecule PRMT6 Inhibitors for the Treatment of Spinal Bulbar Muscular Atrophy (SBMA) Pre-Clinical Development of an ALK2 Inhibitor for the Treatment of DIPG

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.15361120

Author: Sampson, Peter

Institution: Agora

Language: English

Topic: Computational Drug Discovery Methods

Subfield: Computational Theory and Mathematics

Field: Computer Science

Domain: Physical Sciences

Open Access status: green

OpenAlex ID: W6949509446

FWCI:

Cites:

Cited by:

Related to: